We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Repairing Soft Tissues in a Trans-Vaginal Approach

By HospiMedica staff writers
Posted on 27 May 2008
A novel solution for minimally invasive fastening of soft tissue could offer simpler, safer prolapse and stress urinary incontinence (SUI) repair procedures.

The EndoFast Reliant single-incision, trans-vaginal device is intended for soft tissue reinforcement by attaching a mesh to soft tissue using unique fasteners. More...
The tissue-fastening system aids in adapting open, higher-risk procedures to simpler and more effective treatments, reducing associated procedural risk, post-operative side effects, and potentially also reducing the level of anesthesia needed for such procedures. A special spider web-like fastener is inserted into the body via minimally invasive means; this fastens a thin net beneath the organs in a woman's pelvic area, which have collapsed because of age or childbirth. The fasteners are inserted using a gun-like device with a "trigger” that fires the fastener into the tissue. The EndoFast Reliant is a product of Endogun Medical Systems (Kibbutz Haogen, Israel), and has been approved by the U.S. Food and Drug Administration (FDA).

"The FDA approval for our single use, disposable EndoFast Reliant product is a key milestone towards bringing Endogun's products to the prolapse and stress urinary incontinence markets,” said Elad Naggar, Endogun CEO. "This regulatory approval, together with very positive clinical validation from key opinion leaders, indicates a product with a unique value proposition. We believe that our solution may have significant advantages over what is available today, for patients, physicians, payers and providers.”

Pelvic organ prolapse occurs in women--often following multiple births or excess weight--and develops as a result of weakening of the pelvic muscles, which support internal organs (womb, bladder, rectum and vagina). Side effects of this condition include discomfort, a feeling of heaviness, and pain. The disorder carries the risks of inflammation and infection.


Related Links:
Endogun Medical Systems

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.